FINANCIAL CONSULATE, INC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 235 filers reported holding AXSOME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.6%.

Quarter-by-quarter ownership
FINANCIAL CONSULATE, INC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$321,970
-20.0%
5,2200.0%0.11%
-20.6%
Q4 2022$402,619
+72.8%
5,2200.0%0.14%
+43.9%
Q3 2022$233,000
+16.5%
5,2200.0%0.10%
+4.3%
Q2 2022$200,000
-0.5%
5,220
+7.3%
0.09%
+22.1%
Q1 2022$201,0004,8650.08%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 785,683$60,599,73058.10%
Fairmount Funds Management LLC 2,011,647$155,158,33324.61%
VR Adviser, LLC 670,718$51,732,4798.72%
Ghost Tree Capital, LLC 235,000$18,126,0007.74%
SVB FINANCIAL GROUP 33,849$2,610,7737.14%
Tri Locum Partners LP 200,054$15,430,0006.24%
BVF INC/IL 1,755,000$135,363,1505.71%
RTW INVESTMENTS, LP 2,980,482$229,884,5774.69%
TANG CAPITAL MANAGEMENT LLC 320,000$24,681,6003.59%
PFM Health Sciences, LP 1,092,831$84,290,0553.02%
View complete list of AXSOME THERAPEUTICS INC shareholders